RFM/CPAP intervention (RFM/CPAP sub-group only)
hypertension, hypercholesterolaemia
MINOR, HYPERTENSION, RECRUITMENT, HYPERCHOLESTEROLAEMIA
After recruitment to the intervention study, participants with hypertension or hypercholesterolaemia were prescribed appropriate medication and undertook a 1-month run-in stabilisation period. Participants underwent a second PSG at Westmead Hospital Sleep Laboratory to determine the appropriate CPAP treatment pressure [Note: The study described in this manuscript has minor deviations from the registered clinical trial (ACTRN12620000694910). In particular, patients aged ≥43yrs were recruited, smokers were not excluded but smoking status was noted, and the RFM/CPAP sub-group included patients with an RDI ≥ 29 events/hr.